Aquestive Therapeutics Stock (NASDAQ: AQST) stock price, news, charts, stock research, profile.
Open | $3.380 |
Close | $3.090 |
Volume / Avg. | 2.033M / 2.879M |
Day Range | 3.000 - 3.390 |
52 Wk Range | 1.251 - 6.230 |
Market Cap | $282.219M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 37 |
Short Interest | 5.27% |
Days to Cover | 1.7 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Aquestive Therapeutics (NASDAQ: AQST) through any online brokerage.
Other companies in Aquestive Therapeutics’s space includes: Atea Pharmaceuticals (NASDAQ:AVIR), Theravance Biopharma (NASDAQ:TBPH), Zevra Therapeutics (NASDAQ:ZVRA), Xeris Biopharma Holdings (NASDAQ:XERS) and Terns Pharma (NASDAQ:TERN).
The latest price target for Aquestive Therapeutics (NASDAQ: AQST) was reported by Leerink Partners on Friday, May 10, 2024. The analyst firm set a price target for 8.00 expecting AQST to rise to within 12 months (a possible 158.06% upside). 21 analyst firms have reported ratings in the last year.
The stock price for Aquestive Therapeutics (NASDAQ: AQST) is $3.1 last updated May 10, 2024 at 6:06 PM EDT.
There are no upcoming dividends for Aquestive Therapeutics.
Aquestive Therapeutics’s Q2 earnings are confirmed for Monday, August 5, 2024.
There is no upcoming split for Aquestive Therapeutics.
Aquestive Therapeutics is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.